bpc-157 human clinical trials evidence safety regulatory status 🙋🏻‍♂️ Is the lack of data in a red flag? • If a drug could actually knit torn tendons back together in weeks, a trillion-dollar pharmaceutical industry probably wouldn't bury bpc-157 human clinical trials evidence

Adapting the peptide intake schedule to suit personal preferences and goals could result in enhanced advantages, despite its flexibility for consumption at different intervals

1989 Oct;41(4):331-6

If your schedule drifted significantly, pick the most convenient day going forward and commit to it

For example, overexpression of the BRCP/ABCG2 transporter is associated with resistance to several anti-cancer drugs including doxorubicin, mitoxantrone and topotecan [65], whilst ABCB1/MDR1 is frequently overexpressed in drug-resistant cell lines and is found to correlate with poor overall survival in patients [20, 66]

Approximately 20 to 30 percent of users report minimal or no benefit from BPC-157

The food noise has been quieted and combined with the Skinny Shot, I have zero side effects